Ngā hua rapu - Ciccia, Francesco

Whakamahine hua
  1. 1
    Genetic and Environmental Determinants of T Helper 17 Pathogenicity in Spondyloarthropathies

    Genetic and Environmental Determinants of T Helper 17 Pathogenicity in Spondyloarthropathies mā Simone, Davide, Stingo, Alessia, Ciccia, Francesco

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Role of Subclinical Gut Inflammation in the Pathogenesis of Spondyloarthritis

    Role of Subclinical Gut Inflammation in the Pathogenesis of Spondyloarthritis mā Rizzo, Aroldo, Guggino, Giuliana, Ferrante, Angelo, Ciccia, Francesco

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Novel immune cell phenotypes in spondyloarthritis pathogenesis

    Novel immune cell phenotypes in spondyloarthritis pathogenesis mā Mauro, Daniele, Simone, Davide, Bucci, Laura, Ciccia, Francesco

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Intestinal Microbial Metabolites in Ankylosing Spondylitis

    Intestinal Microbial Metabolites in Ankylosing Spondylitis mā Scalise, Giuseppe, Ciancio, Antonio, Mauro, Daniele, Ciccia, Francesco

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Editorial: Ankylosing Spondylitis and Related Immune-Mediated Disorders

    Editorial: Ankylosing Spondylitis and Related Immune-Mediated Disorders mā Fiorillo, Maria Teresa, Haroon, Nigil, Ciccia, Francesco, Breban, Maxime

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Therapeutic Targets for Ankylosing Spondylitis – Recent Insights and Future Prospects

    Therapeutic Targets for Ankylosing Spondylitis – Recent Insights and Future Prospects mā Perrotta, Fabio Massimo, Scriffignano, Silvia, Ciccia, Francesco, Lubrano, Ennio

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort

    Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort mā Perrotta, Fabio Massimo, Scriffignano, Silvia, Ciccia, Francesco, Lubrano, Ennio

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Primary Sjogren Syndrome: Focus on Innate Immune Cells and Inflammation

    Primary Sjogren Syndrome: Focus on Innate Immune Cells and Inflammation mā Rizzo, Chiara, Grasso, Giulia, Destro Castaniti, Giulia Maria, Ciccia, Francesco, Guggino, Giuliana

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis

    Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis mā Ceribelli, Angela, Motta, Francesca, Vecellio, Matteo, Isailovic, Natasa, Ciccia, Francesco, Selmi, Carlo

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study

    Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study mā Scriffignano, Silvia, Perrotta, Fabio Massimo, di Marino, Mario, Ciccia, Francesco, Lubrano, Ennio

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Are Toll-Like Receptors and Decoy Receptors Involved in the Immunopathogenesis of Systemic Lupus Erythematosus and Lupus-Like Syndromes?

    Are Toll-Like Receptors and Decoy Receptors Involved in the Immunopathogenesis of Systemic Lupus Erythematosus and Lupus-Like Syndromes? mā Guggino, Giuliana, Giardina, Anna Rita, Ciccia, Francesco, Triolo, Giovanni, Dieli, Francesco, Sireci, Guido

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Exosomes as Intercellular Signaling Organelles Involved in Health and Disease: Basic Science and Clinical Applications

    Exosomes as Intercellular Signaling Organelles Involved in Health and Disease: Basic Science and Clinical Applications mā Corrado, Chiara, Raimondo, Stefania, Chiesi, Antonio, Ciccia, Francesco, De Leo, Giacomo, Alessandro, Riccardo

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Microbiome Changes in Connective Tissue Diseases and Vasculitis: Focus on Metabolism and Inflammation

    Microbiome Changes in Connective Tissue Diseases and Vasculitis: Focus on Metabolism and Inflammation mā La Barbera, Lidia, Macaluso, Federica, Fasano, Serena, Grasso, Giulia, Ciccia, Francesco, Guggino, Giuliana

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Invariant NKT Cells and Rheumatic Disease: Focus on Primary Sjogren Syndrome

    Invariant NKT Cells and Rheumatic Disease: Focus on Primary Sjogren Syndrome mā Rizzo, Chiara, La Barbera, Lidia, Lo Pizzo, Marianna, Ciccia, Francesco, Sireci, Guido, Guggino, Giuliana

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient

    Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient mā Sagnelli, Caterina, Gentile, Valeria, Tirri, Rosella, Macera, Margherita, Cappabianca, Salvatore, Ciccia, Francesco, Coppola, Nicola

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview

    Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview mā Schinocca, Claudia, Rizzo, Chiara, Fasano, Serena, Grasso, Giulia, La Barbera, Lidia, Ciccia, Francesco, Guggino, Giuliana

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus

    Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus mā Fasano, Serena, Iudici, Michele, Coscia, Melania Alessia, Messiniti, Valentina, Borgia, Alessia, Tirri, Rosella, Ciccia, Francesco

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study

    Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational... mā Ruscitti, Piero, Cipriani, Paola, Liakouli, Vasiliki, Guggino, Giuliana, Carubbi, Francesco, Berardicurti, Onorina, Ciccia, Francesco, Giacomelli, Roberto

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Hyaluronic acid and platelet-rich plasma, a new therapeutic alternative for scleroderma patients: a prospective open-label study

    Hyaluronic acid and platelet-rich plasma, a new therapeutic alternative for scleroderma patients: a prospective open-label study mā Pirrello, Roberto, Verro, Barbara, Grasso, Giulia, Ruscitti, Piero, Cordova, Adriana, Giacomelli, Roberto, Ciccia, Francesco, Guggino, Giuliana

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Vγ9/Vδ2 T lymphocytes in Italian patients with Behçet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor β(1 )expression in active disease

    Vγ9/Vδ2 T lymphocytes in Italian patients with Behçet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor β(1 )expression in activ... mā Triolo, Giovanni, Accardo-Palumbo, Antonina, Dieli, Francesco, Ciccia, Francesco, Ferrante, Angelo, Giardina, Ennio, Sano, Caterina Di, Licata, Giuseppe

    I whakaputaina 2003
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: